POVTENZI Trademark

Trademark Overview

On Tuesday, June 24, 2025, a trademark application was filed for POVTENZI with the United States Patent and Trademark Office. The USPTO has given the POVTENZI trademark a serial number of 99250865. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 14, 2025. This trademark is owned by Vertex Pharmaceuticals Incorporated. The POVTENZI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and dis...
povtenzi

General Information

Serial Number99250865
Word MarkPOVTENZI
Filing DateTuesday, June 24, 2025
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 19, 2025

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, July 10, 2025ASSIGNED TO EXAMINER
Monday, July 14, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 13, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 19, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 19, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 24, 2025NEW APPLICATION ENTERED
Tuesday, June 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 24, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

povtenzi treatment preparations pharmaceutical diseases immune disorders autoimmune hemolytic anemia nephropathy